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 25 
ABSTRACT 26 
Escherichia coli strains were isolated from a single dairy farm as a sentinel organism for the 27 
persistence of antibiotic resistance genes in the farm environment. Selective microbiological media 28 
were used to isolate 126 E. coli isolates from slurry and faeces samples from different farm areas.  29 
Antibiotic resistance profiling for 17 antibiotics (seven antibiotic classes), showed 57.9% of the 30 
isolates were resistant to between 3 and 15 antibiotics. The highest frequency of resistance was to 31 
ampicillin (56.3%), and the lowest to imipenem (1.6%), which appeared to be an unstable phenotype 32 
and was subsequently lost. Extended spectrum beta-lactamase resistance (ESBL) was detected in 53 33 
isolates and blaCTX-M, blaTEM and blaOXA genes were detected by PCR in twelve, four and two strains, 34 
respectively. Phenotypically most isolates showing resistance to cephalosporins were AmpC rather 35 
than ESBL, a number of isolates having both activities. Phenotypic resistance patterns suggested co-36 
acquisition of some resistance genes within subsets of the isolates. Genotyping using ERIC PCR 37 
demonstrated these were not clonal, and therefore co-resistance may be associated with mobile 38 
genetic elements. These data show a snapshot of diverse resistance genes present in the E. coli 39 
population reservoir, including resistance to historically used antibiotics as well as cephalosporins in 40 
contemporary use. 41 
 42 
 43 
 44 
 45 
 46 
 47 
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INTRODUCTION 48 
The use of antibiotics in agriculture and animal husbandry is increasingly being considered a global 49 
health issue, both from the animal health and welfare aspect, and because of the development of 50 
antibiotic resistance in animal pathogens (Davies 2013; O'Neill 2015). In the UK from 2006-2011, 51 
(after the EU ban on antibiotic use as a growth promoter), about 400 tonnes of antibiotics were used 52 
annually in treatment of food-producing animals (Wellington et al. 2013) which is more than the 53 
amount used in humans. Animal manure is a major source of antimicrobial resistant bacteria 54 
entering the environment, especially the soil (Aarestrup et al. 1996; Binh et al. 2007; Ghosh and 55 
LaPara 2007), and it has been estimated that annually about 70 million tonnes of animal manure are 56 
used as fertilizer on agricultural land in the UK (Hutchison et al. 2004). Much of this will contain low 57 
levels of antibiotics or antibiotic metabolites/conjugates, and antimicrobial resistant bacteria.  58 
 Escherichia coli serves as a sentinel organism for antimicrobial resistance development in different 59 
types of animals, because it is a common enteric commensal, can be a pathogen, and easily acquires 60 
resistance and therefore can act as a reservoir which can transfer resistance to other 61 
species/pathogens (Aarestrup et al. 1998; van den Bogaard et al. 2000; Allen et al. 2010; Ashbolt et 62 
al. 2013). Cephalosporin antibiotics are commonly used in dairy veterinary medicine because they 63 
are effective in treating environmental mastitis caused largely by E. coli strains (Shpigel et al. 1997). 64 
Of particular concern has been the emergence and spread of extended spectrum beta lactamase 65 
(ESBL) producing E. coli associated with cattle and other farm animals (Bush and Jacoby 2010; Pfeifer 66 
et al. 2010). Both ESBL and AmpC ß-Lactamases can confer resistance to third generation 67 
cephalosporins, penicillins and monobactams. These two groups of enzymes are very distinct and 68 
can mainly be differentiated by different susceptibility patterns against β-lactam site-specific 69 
inhibitors such as clavulanic acid, their differences in activity against fourth generation 70 
cephalosporins such as cefepime, and cephamycins such as cefoxitin (Moritz and Carson 1986; 71 
Livermore et al. 2001; Bush and Jacoby 2010; CLSI 2013a). To date, more than 220 TEM, 190 SHV, 72 
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and 160 CTX-M ESBL enzyme variants, have been described, and more than 230 variants from the 73 
different plasmid AmpC families are known, 136 of which belong to the CMY family (www.lahey.org/ 74 
studies). 75 
In the dairy farm studied, cephalosporins were used for treatment of environmental mastitis caused 76 
by E. coli, and mastitic milk was discarded into the slurry tank, which may potentially select for E. coli 77 
strains carrying ESBL. The aim of this study was to determine the prevalence and range of ESBL 78 
resistance in E. coli within the farm, to understand the diversity of resistance to β-lactam antibiotics, 79 
and to determine if co-carriage of other antimicrobial resistance (AMR) was associated with ESBL 80 
resistance.  This would allow a better understanding of the contributions that farms and farm waste 81 
may make to persistence of AMR in the environment, and the reservoir of resistance in agriculture.  82 
 83 
Materials and Methods 84 
Dairy Farm Unit 85 
The farm has a herd of approximately 200 dairy cows. The animals are milked using an automated 86 
milking system, and consequently the milking cows are housed for the majority of the year inside 87 
barns. Each cow produces 60-70 kg of waste per day, which is automatically scraped into a sump, 88 
daily.  Slurry solids are mechanically separated and deposited into a trailer, where it goes to a heap 89 
or is directly used as a fertilizer. The remaining liquid slurry, containing approximately 5% solids, is 90 
pumped into an on-site slurry tank and stored for field spreading. The slurry tank has a capacity of 3 91 
million litres and is generally emptied after circa 90 days, either into a slurry lagoon by means of a 92 
pipeline, or is pumped into a tanker and taken directly to fields for spreading. The major use of 93 
antibiotics on the farm is to treat mastitis infections, which occur at a rate of ~100 incidences per 94 
year, i.e. approximately one every 3 days. At the time of this study, these infections were treated 95 
Page 5 of 37
ScholarOne Support 1-434/964-4100
FEMS Microbiology Ecology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
5 
 
with cephalosporin antibiotics (Cefquinome- 4
th
 generation cephalosporin- veterinary use only) 96 
through intramammary infusion directly into the infected quarter; the withheld milk was disposed of 97 
into the slurry tank, alongside waste footbath contents, washing water and other cleaning solutions 98 
and disinfectants used in the dairy unit. Cefquinome was also used as a prophylactic to prevent 99 
mastitis when cows were dried off before entering another lactation cycle. Other antibiotics had 100 
been used on the farm for treatment  of other bacterial infections common to dairy cattle including: 101 
ceftiofur (3
rd
 generation cephalosporin- veterinary use only), cephalexin (1st generation 102 
cephalosporin), oxytetracycline, penicillins, aminoglycosides and aminocoumarin antibiotics. 103 
 104 
Samples  105 
Slurry samples were collected from different areas in the dairy unit in December 2012 and March 106 
2014. In all cases samples were kept at 4°C and isolation of E. coli started within 48 h of collection. 107 
Three biological replicates were taken from each sample and individually serially diluted in maximum 108 
recovery diluent (MRD; Oxoid, UK), and duplicate 100 µL samples spread onto selective media. In the 109 
preliminary study in 2012, samples were taken from the slurry tank (n=2), separated solid slurry 110 
(n=1), cow faeces solid (n=1) and liquid exudate (n=1) and E. coli isolated by plating on tryptone bile 111 
X-glucuronide agar (TBX agar; Merck) with overnight incubation at 37°C. In the 2014 study, samples 112 
from liquid slurry taken from the slurry tank (n=3), separated solid slurry (n=3), and cow faeces from 113 
animal housing (n=3) were plated on TBX agar, TBX containing cefotaxime (CTX; 2 mg L
-1
) and 114 
CHROMagar ESBL (BioConnections, UK).  All plates were incubated overnight at 37
◦
C. E. coli NCTC 115 
13353 and E. coli ATCC 25922 were used as ESBL positive and negative control strains, respectively. 116 
In general, for each sample five colonies were picked from each of the TBX and TBX + CTX plates, and 117 
most of the pink colonies from the CHROMagar ESBL plates and were purified using LB agar (Fisher 118 
Scientific, USA).  In total 155 colonies were selected from different media: in 2012 25 colonies from 119 
TBX; in 2014 35 colonies were selected from CHROMagar ESBL, 47 colonies from TBX and 48 colonies 120 
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from TBX+CTX. All isolates were tested for indole production (Collins et al. 2004) and oxidase activity 121 
(Oxidase Detection sticks, Oxoid); and indole positive, oxidase negative strains were considered as E. 122 
coli.  API 20E tests (BioMerieux, France) were used to confirm identification for selected isolates. All 123 
confirmed isolates were immediately stored as Microbank (Pro-Lab Diagnotics UK)  bead stocks at -124 
80°C, and were grown from frozen stocks for each subsequent characterization. 125 
 126 
 Antibiotic sensitivity tests  127 
The disc diffusion antibiotic sensitivity tests were carried out according to the National Committee 128 
for Clinical Laboratory Standards (NCCLS) and Clinical and Laboratory Standards Institute (CLSI) 129 
guidelines with some modifications (NCCLS 2002 ; CLSI 2012). Four or five bacterial colonies were 130 
taken from LB plates which had been inoculated and incubated overnight at 37
◦
C. The colonies were 131 
suspended in 5 mL of Muller-Hinton broth (Oxoid, UK) and incubated for 16 h at 37
◦
C. Each sample 132 
was diluted with sterile water until it reached a 0.5 McFarland standard concentration. Then, 100 µL 133 
of the culture was pipetted onto the surface of a 25 mL Muller-Hinton agar plate (Oxoid, UK), and 134 
the inoculum was distributed by spreading using an L-shaped spreader.  The plates were left to dry 135 
at room temperature (for no more than 15 min), and the antibiotic discs were placed on to the plate 136 
surface, with 4-5 antibiotic discs on each plate. The plates were then incubated at 37
◦
C for 18-24 h, 137 
and the results recorded by measuring the inhibition zone diameter across the disc and then 138 
interpreted according to standard measurement tables (CLSI 2013a, b). All antibiotics used in the 139 
tests are listed in Table 1; all discs were supplied by Oxoid (UK), except for Cefquinome 140 
(Bioconnection, UK ):  the quality control strains used were E. coli ATCC 25922 (ESBL negative) and E. 141 
coli NCTC 13353 (ESBL positive CTX-M-15). 142 
 143 
 144 
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Phenotypic confirmation of ESBL/AmpC-producing E. coli 145 
Phenotypic detection of ESBLs can be obscured by AmpC-producing bacteria. All isolates that gave 146 
an inhibition zone indicating resistance or intermediate resistance to cefotaxime, and/or ceftazidime 147 
using standard antibiotic discs were further tested using the Total ESBL Confirm Kit (Rosco 148 
Diagnostica, France; product code 98014) containing a combination of cefotaxime (CTX), ceftazidime 149 
(CAZ), and cefepime (FEP) discs (30 μg of each antibiotic) alone and in combination with clavulanic 150 
acid (CA). The test was performed in accordance with the guidelines of the manufacturer.  An 151 
increase in the diameter of the zone of clearing around the disc by ≥ 5-mm for either antimicrobial 152 
agent tested in combination with CA vs the diameter of the zone of clearing around a disc containing 153 
the agent when tested alone, indicated ESBL presence (CLSI 2013a; EUCAST 2013). The total ESBL kit 154 
is composed of 6 discs, the first 4 are recommended to be used by CLSI while the other two (FEP and 155 
FEP+C) are further recommended by EUCAST to confirm that resistance is due to ESBL, and not 156 
chromosomal AmpC, as chromosomal AmpC does not confer  resistance to cefepime. 157 
In addition, a cefoxitin (FOX) disc (30 μg, Oxoid, UK) was added to the test, to detect AmpC 158 
phenotypes, as it is known that AmpC producers are resistant to cefoxitin, one of the cephamycin 159 
group.  160 
The presence of hyper-produced and de-repressed/plasmid mediated AmpC beta-lactamase was 161 
detected using the AmpC Confirm Kit (Rosco Diagnostica; product code 98007), where a ≥ 5-mm 162 
increase in the inhibition zone diameter of cefotaxime 30 µg + cloxacillin (CTXCX) or ceftazidime 30 163 
µg + cloxacillin (CAZCX) compared with the inhibition zone for the antibiotics alone indicated the 164 
presence of de-repressed/plasmid encoded AmpC, inhibited by cloxacillin. Control strains used were 165 
E. coli ATCC 29522 (ESBL negative control), E. coli NCTC13353 (ESBL positive) and Enterobacter 166 
cloacae NCTC 13406 (AmpC β-lactamase de-repressed). 167 
 168 
Clustering of resistance profiles 169 
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For consistency, antibiotic resistance scores of less than 6 (nominal disc size in mm) were replaced 170 
with 6 as a minimum score.  Clustering of antibiotic sensitivity profiles was carried out using the 171 
heatmap.2 function in the gplots library (version 2.17.0) in the R software package (version 3.2.0). 172 
Euclidean distance was used for both row (bacterial strain) and column (antibiotic) dissimilarity. 173 
Clustering used complete linkage. Clustering was used for data visualization, so no formal statistics 174 
were run. 175 
 176 
Genotyping of isolates 177 
DNA extraction 178 
Bacterial DNA was extracted by dispersing one colony of E. coli from an overnight culture on LB agar 179 
into 100 μL of sterile 1 x TE buffer (10 mM Tris-Cl, 1 mM EDTA buffer, pH 7.6). The suspension was 180 
heated to 100°C for 30 min to rupture bacterial cells (Eppendorf Thermomixer Comfort, Germany) 181 
and then centrifuged (Heraeus Pico17 centrifuge, UK) at 13 000 x g for 15 min. The crude DNA in the 182 
supernatants was transferred into sterile microcentrifuge tubes and stored at -20 ˚C until use (total 183 
DNA). 184 
 185 
PCR detection of ESBL genes  186 
All phenotypically ESBL isolates were screened for blaSHV, blaTEM, blaOXA-1, blaOXA-2 and blaCTX-M genes 187 
using PCR as described by Dierikx and co-workers (2012). Total DNA (2 µL) was used in a 25 µL 188 
reaction mixture which contained 12.5 μL of DreamTaq Green PCR master mix (2X) (ThermoFisher 189 
Scientific, UK) (containing DreamTaq™ DNA polymerase, optimized DreamTaq Green buffer, 0.4 mM 190 
of each of the dNTPs, 4 mM MgCl2), 8.5 μL of nuclease free water, and 1 μL (10 µM) of each primer. 191 
The primers and expected PCR product sizes are given in Table 2. E. coli NCTC 13353 was used as 192 
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positive control for CTX, E. coli NCTC 13352 was used as a positive control for TEM, and Klebsiella 193 
pneumoniae NCTC 13368 was used as a positive control for SHV. E. coli ATCC 25922 was used as a 194 
negative control for PCR. 195 
 All oligonucleotides were synthesized by Eurofins MWG Operon, Germany. A programmable 196 
C1000™ Thermal cycler (Bio-Rad, UK) was used to carry out the reactions under the following 197 
conditions: one cycle of denaturation for 5 min at 94˚C followed by 30 cycles of 30 s at 94˚C, 30 s at 198 
55˚C and 60 s at 72˚C, with a final extension of 7 min at 72˚C.  The PCR product (7 μL) was loaded 199 
onto a 2% w/v agarose gel, containing ethidium bromide (0.4 μg mL
-1
) in 1x TAE running buffer (40 200 
mM Tris-acetate, 1 mM EDTA) and electrophoresed at 120 V for 1 h. A 100 bp DNA size marker 201 
(Invitrogen, UK) was used in each gel.   202 
 203 
PCR detection for plasmid ampC 204 
A multiplex PCR assay was carried out as described in Dallenne et al. (2010) to detect plasmid ampC 205 
genes from six families: ACC, FOX, MOX, DHA, EBC and CIT. The PCR reactions were carried out in a 206 
50 µL PCR mixture including 25 µL of DreamTaq Green PCR master mix (2X), 1 µL of each forward 207 
and reverse primer for all families, except for FOX and DHA where 2.5 µL of each of the forward and 208 
reverse primers were used, 5 µL of nuclease free water and 2 µL of DNA. The PCR cycle started with 209 
an initial denaturing step of 10 min at 94°C and then 30 cycles of 94°C (40 s), 60°C (40 s) and 72°C (60 210 
s). The PCR reaction ended with a final extension step of 72°C for 7 min. All primers are listed in 211 
Table 2. 212 
 213 
ERIC PCR 214 
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Genotypes were investigated using the ERIC-PCR method (Versalovic et al. 1991). The PCR mixture 215 
(25 μL) contained 12.5 μL of DreamTaq Green PCR master mix (2X), 9.5 μL nuclease free water, 1 μL 216 
DNA and 1 μL (10 µM) of each primer: ERIC1 (forward) and ERIC2 (reverse) (Eurofins MWG Operon, 217 
Germany) (Table 2). A programmable C1000™ Thermal cycler was used to carry out the reactions, 218 
using the following conditions: one cycle for 3 min at 94˚C, 35 cycles of: 30 s at 94˚C, 1 min at 52˚C, 219 
and 4 min at 65˚C. The final cycle was for 8 min at 65˚C. The PCR product (7 μL) was loaded onto a 220 
2% w/v agarose gel, as described above and electrophoresed at 120 V for 2 h. A 1 kb plus DNA size 221 
marker (Invitrogen, UK) was included on every gel to allow cross gel comparison. After 222 
electrophoresis, the gel was imaged using a Gel-Doc XR system (Bio-Rad, UK) and the image analysed 223 
using FPQuest gel analysis software V4.5 (Bio-Rad, UK). A dendrogram was obtained from the 224 
comparison of ERIC-PCR profiles, using the Dice coefficient, and clustered by the unweighted pair 225 
group method with arithmetic averages (UPGMA) with 1.5% of optimization and 1.5% of tolerance 226 
to display the dendrogram. Molecular variance framework (AMOVA; Excoffier et al. 1992) was used 227 
to analyse the confidence of the selected similarity threshold and the significance of clusters. The 228 
AMOVA calculation was carried out using GenAlEx v 6.5b5 software (Peakall and Smouse 2006). The 229 
significance was examined with the calculation of ΦPT, a measure of population differentiation that 230 
suppresses intra-individual variation. In the case of AMOVA, the null hypothesis (H0; ΦPT = 0) meant 231 
that there was no genetic difference among the populations and the alternative hypothesis (H1; ΦPT 232 
>0) meant there are genetic differences amongst the populations.  233 
 234 
Results 235 
Samples 236 
 E. coli strains were isolated from all of the farm samples using the different selective media; 126 out 237 
of 155 isolates were confirmed as E. coli. Many of the colonies isolated on the ESBL CHROMagar
TM 
238 
Page 11 of 37
ScholarOne Support 1-434/964-4100
FEMS Microbiology Ecology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11 
 
gave typical colony characteristics for E. coli, but the confirmation tests did not confirm this 239 
identification and they were excluded from further analysis. Strain numbering is indicative of source 240 
and medium of isolation: A designates a 2012 strain isolated on TBX; B designates 2014 isolates: BL 241 
liquid slurry, BS slurry solids, BC cattle faeces from the cow barn; a further suffix C designates CTX 242 
agar, suffix E is CHROMagar ESBL, no suffix is TBX without antibiotic selection. For the 2012 strains, 243 
numbers following A indicate sampling site: 1 and 2 designate the slurry tank, 3 solid cow faeces, 4 244 
liquid exudates from solid faeces, and 5 separated solid slurry.  245 
 246 
Antibiotic Resistance   247 
One hundred and twenty six (2012/14) confirmed E. coli isolates from TBX, TBX + CTX and 248 
CHROMagar ESBL were tested against 17 antibiotics (representing seven antibiotic groups) using 249 
standard disc diffusion antibiotic sensitivity tests (Table 1). Only 7.9% of isolated strains were 250 
sensitive to all antibiotics whereas 92% showed resistance to at least 1 antibiotic of which 27.8%, 251 
(35) of the isolates were isolated on TBX and showed resistance to at least one antibiotic. 57.9% (73) 252 
of the isolates were multidrug resistant (MDR- as defined in Magiorakos et al. 2012) and showed 253 
resistance to three or more antibiotics from three different antibiotic groups. The resistance profile 254 
of MDR strains ranged from 3-15 antibiotics Figure 1 and 2). The isolate with the highest number of 255 
resistances (BCC2) (Figure 3) was sensitive only to imipenem and ceftazidime. The highest 256 
percentages for MDR isolates were from solid slurry, 26.1% (33 isolates); then cow accommodation 257 
slurry, 19.8% (25 isolates) and from liquid slurry 11.9% (15 isolates). 258 
 With regard to the prevalence of resistance to each antibiotic, Figure 2 shows the percentage of 259 
strains resistant to each tested antibiotic. Amongst the strains tested, the highest percentage 260 
resistance was to ampicillin (56.3%), followed by oxytetracycline, streptomycin, and sulphonamide 261 
(41.1%, 39.6%, and 37.3% respectively). Dihydrofolate reductase inhibitors, such as trimethoprim 262 
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were tested in combination with sulfamethoxazole and 12.6% of the E. coli isolates were resistant to 263 
this combination, while the resistance to chloramphenicol and nitrofurantoin was 8.7% for both. It is 264 
worth noting that ampicillin was one of the most widely used antibiotics for veterinary use in the UK 265 
between 2006-2011, as well as tetracycline and trimethoprim/sulphonamides (DEFRA 2012).  266 
Furthermore, the isolates showed a range of resistance to different antibiotics from the 267 
cephalosporin family: 38%, 14.2% and 23% were resistant to cefotaxime, ceftazidime and ceftiofur, 268 
respectively, which are all third generation cephalosporins, while 11.1% of the isolates were 269 
resistant to cefquinome, which is a fourth generation cephalosporin. This is not surprising as 270 
approximately 48% (59 isolates were from selective media: 15 from CHROMagar ESBL and 44 from 271 
TBX+CTX) of the isolates were directly selected on media containing beta-lactam antibiotic 272 
supplements. Quinolone antibiotics were still largely effective against these strains, with only 3.1% 273 
of the E. coli isolates resistant to both ciprofloxacin (CIP) and enrofloxacin (ENR). 1.6% (2) of the E. 274 
coli isolates were phenotypically resistant to imipenem (IMP), with 3.2% (4) showing intermediate 275 
sensitivity, but subsequent characterization of the imipenem resistant strains showed this resistance 276 
was not stable. The highest intermediate resistance was against streptomycin (S10) (36.5%) and 277 
aztreonam (ATM) (23.8%). 278 
 279 
Clustering of Antibiotic Sensitivity 280 
When the antibiotic resistance profile of each E. coli strain was clustered (Figure 3) using the 281 
heatmap.2 function of the R statistical package, the analysis showed that, with some exceptions, the 282 
isolates mainly clustered together based on the selective medium which was used to isolate them. 283 
The strains isolated on TBX medium and then tested for antibiotic resistance were more diverse in 284 
their resistance patterns than those isolated on TBX+CTX. The latter clustered in two groups with the 285 
majority of isolates showing clustered resistance to ampicillin (AMP), streptomycin (S10), 286 
oxytetracycline (OT) amoxicillin-clavulanic acid (AMC) and sulphonamide (S300). The majority of 287 
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those isolated on CHROMagar ESBL formed a closely related resistance cluster, with ESBL resistance 288 
to cefquinome (CFQ), ceftiofur (EFT), ceftazidime (CAZ), cefotaxime (CTX) and aztreonam (ATM) 289 
(Figure 3). Several strains that were isolated on TBX +CTX (BCC1, BSC22) or TBX (BS9) clustered with 290 
the CHROMagar isolates, and showed this same cluster of resistances while some CHROMagar ESBL 291 
isolates which clustered in the TBX cluster (BSE1, 7, 3, 5,  9, 4) lacked them.  292 
 293 
Phenotyping and PCR typing of ESBL resistances and genes 294 
ESBL/AmpC phenotypes were tested in the 53 strains that were found to be resistant to cefotaxime/ 295 
ceftazidime in the initial antibiotic sensitivity assays (Table 3). These tests showed that 25/53 296 
(47.1%) strains were phenotypically ESBL using the confirmatory test kits. The strains were also 297 
tested by PCR for the presence of blaCTX-M, blaTEM, blaOXA1 and OXA2, or blaSHV beta lactamases. No blaSHV 298 
beta-lactamases were detected, but blaCTX-M (22.6%; 12 positive) and blaTEM (7.5%; 4 positive) were 299 
both detected in the ESBL isolates, including examples of both in the same isolate (BCE3 and BCC2), 300 
blaOXA1 was present in two (3.7%) isolates, but not in the ESBL isolates, as well as two of the isolates 301 
that were positive for TEM but were not phenotypically ESBL: BS7 and A2.5 (Figure 3).  302 
Phenotypic AmpC resistance was identified in 36 isolates, initially by the lack of activity of cefepime 303 
against these strains. This was further confirmed when the cefoxitin disc assay showed no activity 304 
against the strain. However, cefoxitin resistance can be due to decreased cell wall permeability 305 
(Brenwald et al. 2005); so full confirmation was if the inhibition zone diameter for CTX and CAZ discs 306 
compared to CTX + cloxacillin, and CAZ + cloxacillin was ≥ 5-mm larger than in the discs containing 307 
antibiotic alone, as AmpC activity against cephalosporins is inhibited by cloxacillin. Eight isolates 308 
(15.0%) had both ESBL and AmpC activity; those strains were BCC12, BCC7, BLC5, BSC14, BSC19, 309 
BSC3, BSC4 and BSC9 (Figure 4 and Table 3). PCR tests for the presence of plasmid ampC genes from 310 
the six major families: ACC, FOX, MOX, DHA, EBC and CIT, were negative for all 36 of the 311 
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phenotypically AmpC strains, suggesting that the AmpC phenotype in the farm E. coli isolates was 312 
chromosomal gene hyperproduction. 313 
 314 
Genotyping of E. coli strains using ERIC PCR 315 
The similarity of the ERIC-PCR profiles of the E. coli isolates from different sampling sites was 316 
analysed, and cluster analysis divided strains into six main groups at a 50% similarity threshold which 317 
cluster significance analysis demonstrated were non-overlapping and hence genomically 318 
independent groups (cluster significance ΦPT=0.48; P<0.001). There was no significant association of 319 
clusters with source of isolation, with most groups containing isolates from all three sources: cow 320 
barns, slurry tank and solid slurry.  Some solid slurry isolates did associate closely in  separate 321 
clusters in groups IV and V, suggesting this distinct genotype may be partitioning with the solids.  322 
Noticeably there was little correspondence of ERIC clusters with the clusters generated in the 323 
antibiotic resistance heat map (Figures 3 and 5).  Groups of strains with identical ERIC profiles such 324 
as BC12, BC14, BC15, BC7, BL15, BLC4, BS10, BS9, were widely dispersed in the resistance 325 
dendrogram.  Similarly strains showing close similarity in their resistance profile were not always 326 
related at the genomic level.  Hence the multidrug resistant strains that were resistant to AMP, S10, 327 
OT, S300 and AMC do not represent a genomically clonal group.  This suggests that this co-resistance 328 
may be due to a mobile genetic element which has transferred between multiple strains.  A further 329 
example is seen in strains BSC7, BSC18, BSC20, all from solid slurry samples and all with the same 330 
ERIC profile; strain BSC20 is sulphonamide-trimethoprim (SXT) resistant, which the other two strains 331 
are not and could demonstrate gene acquisition e.g. through a resistance plasmid. There were many 332 
similar examples of strains with identical (ie 100%S) ERIC profiles showing variability in their 333 
resistances. This suggests that in this environment there is a genomically variable E. coli population 334 
in which there is conservation of antimicrobial resistance carrying genetic elements.  This was 335 
further substantiated by comparison of the 2014 isolates with the 20 E. coli strains from the 336 
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preliminary study in 2012.  In comparison to the 2014 isolates, the ERIC profiles of the 2012 isolates 337 
(A-strains) partitioned them into a separate group on the dendrogram (Figure 5), showing them to 338 
be a quite distinct genetic population; all these strains were isolated on TBX agar without antibiotic 339 
selection, and whilst there was some subclustering of this group of isolates on the resistance heat 340 
map (Figure 3), not all isolates clustered together.  Strain A2.5 from 2012 (VI group) isolated from 341 
the slurry tank showed multiresistance to 11 antibiotics including the AMP, S10, OT, S300 and AMC 342 
multiresistance phenotype seen amongst the 2014 strains and this isolate clustered together with 343 
these 2014 strains on the resistance heat map (Figure 3).  This again is suggestive of conservation of 344 
the genetic determinant(s) over 2 years, rather than conservation of a clonal line.   345 
 346 
Discussion 347 
Escherichia coli is a common enteric commensal, specific strains of which can cause human and 348 
animal disease. It is one of the group of seven species that the WHO has highlighted as of key AMR 349 
concern and serves as a sentinel organism for antimicrobial resistance development. Of particular 350 
concern has been the emergence and spread of ESBL producing E. coli associated with cattle and 351 
other farm animals (Liebana et al. 2013).  The recent report of transferable colistin resistance in 352 
commensal E. coli from farm animals and the presence of the same resistance genes in isolates from 353 
meat and E. coli and Klebsiella pneumoniae from patients has highlighted the threat that resistance 354 
genes originating in animals can subsequently be spread to humans (Liu et al. 2015).  355 
In this study we determined the antibiotic resistance pattern of E. coli strains isolated from different 356 
cattle slurry sources in a dairy farm unit, with a focus on ESBL mediated resistance. On this farm (as 357 
will be the case in others worldwide) different types of antibiotics are being given to treat the cattle, 358 
and this will make a contribution to antibiotic resistance gene selection and gene horizontal transfer 359 
among different species of bacteria. To our knowledge, similar studies on MDR E. coli from cattle 360 
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slurry within one dairy farm have not been performed, or have been performed with different 361 
methodology or materials, such as the antibiotics that were used to challenge the strains. 362 
Comparison with other studies would not necessarily give the same patterns of resistance, as each 363 
farm has a different management regime regarding housing the cattle, the type of cattle, their 364 
nutrition and veterinary treatments, disposal of antibiotic-contaminated mastitic milk, use of 365 
disinfectants and other antimicrobials, and slurry handling. Studying resistance to different groups of 366 
antibiotics in a sentinel species (E. coli) has given us an indication of the reservoir of resistance that 367 
is present in the farm bacterial population. It is worth mentioning that the source of the isolates is a 368 
well-managed farm with complete records of the antibiotics that are being used for disease 369 
treatment.    370 
This study showed that MDR E. coli were present in all samples. However, the faecal samples from 371 
the barns and the solid slurry carried more resistant isolates compared to samples from the liquid 372 
slurry. This might be due to the dilution that happens to the bacterial levels contained in the slurry 373 
tank, as wastewater from cleaning the barns and the milking equipment is disposed of into the slurry 374 
tank, and the slurry tank is open-topped and receives rain water.  375 
The total percentage of MDR strains resistant to 3 or more antibiotics was 57.9% (73 isolates) 376 
(including ESBL resistance and resistance to other antibiotics) of which 43.6% (55 isolates) were 377 
strains that were isolated using extend spectrum cephalosporin ESC selective media (TBX + CTX and 378 
CHROMagar ESBL), whilst the percentage of MDR E. coli isolated on TBX without antibiotic selection 379 
was 14.2% (18 isolates) (to all tested antibiotics).  This difference will reflect the effectiveness of the 380 
direct selection method, and may also be due to the difference in prevalence of MDR E. coli between 381 
different sampling times. This was in line with another study which found that ESBL-producing E. coli 382 
can be isolated from cattle farms more than twice as often using selective enrichment procedures 383 
(Schmid et al. 2013). What was surprising was that the different isolation media isolated different 384 
subpopulations of resistant E. coli from the same samples. The same multiple antibiotic resistances 385 
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were more frequently seen when an extended spectrum cephalosporin antibiotic (ESC) was used for 386 
selective isolation. 387 
The presence of ESBL-mediated resistance in the isolates was not surprising given the use of 388 
cephalosporins for mastitis treatment in the herd. What was more unexpected was the level of 389 
resistance carriage to older antibiotics, with resistance to oxytetracycline, streptomycin and 390 
sulphonamide seen in over a third of strains. Co-acquisition of these resistance genes with ampicillin 391 
resistance was strongly indicated in TBX+CTX isolates (Figure 3) and may indicate the presence of a 392 
multi-resistance genetic element present in these isolates. Schmid et al. (2013) found ESBL E. coli 393 
from some farms which did not use β-lactam antibiotics and they suggested that the presence of 394 
such isolates is due to using other classes of antibiotics that can select for ESBLs as well. In a previous 395 
study of E. coli strains isolated from cattle, most strains were resistant to ampicillin (64%), 396 
tetracycline (74%), streptomycin (60%), sulphonamide (76%) with low occurrence (1%) of 397 
enrofloxacin resistance (EMEA 1999). In a later study by Nováková et al. (2009), all the E. coli isolates 398 
from dairy calves and lambs showed multi-resistance to tetracycline, streptomycin and compound 399 
sulphonamides with less resistance to enrofloxacin (Nováková et al. 2009). The resistance patterns 400 
observed in the current study mirror these findings, and resemble a historical record of antibiotic 401 
use and development of resistance to them (Toleman and Walsh 2011), and may represent a genetic 402 
archaeology of the use of veterinary antimicrobials.     403 
According to Jacoby and Sutton (1991), resistance determinants against aminoglycosides, 404 
tetracycline, sulphonamides and cephalosporins, are often situated on the same plasmid. 405 
Metagenomics, PCR and exogenous plasmid isolation studies of cow manure have also detected 406 
diverse resistance genes (Jacoby and Sutton 1991; van Overbeek et al. 2002; Wichmann et al. 2014). 407 
Plasmids and transposons that carry multi antimicrobial resistance genes can also carry genes 408 
mediating resistance to toxic metals, virulence, and metabolic functions, for example Tn1691 409 
specifies resistance to mercury as well as to some antibiotics: streptomycin, sulphonamides, 410 
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chloramphenicol (Barbosa and Levy 2000). This could indicate that there are factors other than 411 
veterinary medicines leading to retention of antibiotic resistances within the dairy herd and the farm 412 
environment.  413 
The finding that two strains were resistant to imipenem was unexpected and of concern. 414 
Confirmatory testing of these isolates showed initial retention of imipenem resistance but on further 415 
retesting the strains reverted to imipenem sensitivity, a phenomenon which has been reported 416 
elsewhere (Villa et al. 2013) and which can be associated with loss of plasmid carriage of genes.  417 
The most frequently encountered ESBL genes in Enterobacteriaceae belong to the TEM, SHV and 418 
CTX-M families (Paterson and Bonomo 2005), and the number of novel gene variants is still 419 
increasing as different genes are being described (http://www.lahey.org/studies/).  This study 420 
showed the presence in ESBL E. coli in one dairy farm of blaCTX-M (12 strains), and blaTEM (4 strains), 421 
blaOXA (2 strains) but not blaSHV and presence of E. coli carrying chromosomal ampC resistance. Nine 422 
of the 12 blaCTX-M positive, and one of the four blaTEM positive E. coli strains were isolated on 423 
CHROMagar ESBL, although six of the other strains isolated on this medium were not positive for 424 
blaCTX-M and blaTEM. In two cases E. coli isolates (BCE3 and BCC2) were shown to carry both blaCTX-M, 425 
and blaTEM. Thirty six isolates were confirmed as having resistance phenotypes consistent with 426 
hyperproduction of AmpC. The phenotypic differentiation between plasmid-borne and chromosomal 427 
AmpC resistance in E. coli is difficult. Although the AmpC β-lactamase enzyme is normally encoded 428 
by a non-inducible chromosomal gene (Honore et al. 1986; Philippon et al. 2002; Jacoby and Munoz-429 
Price 2005; Jacoby 2009), hyper-production can arise, either by mutations at the ampC attenuator or 430 
promoter regions, or by gene amplification (Caroff et al. 1999; Nelson and Elisha 1999; Philippon et 431 
al. 2002). In bacteria that lack chromosomal ampC, phenotypic differentiation is easier, as the 432 
difference in beta-lactamase activity between ESBL and AmpC strains can be seen in the difference 433 
in sensitivity towards cefoxitin (to which AmpC is resistant) and Beta lactamase inhibitor 434 
combinations: clavulanic acid and EDTA (to which ESBL is sensitive)(Black et al. 2005; EUCAST 2013). 435 
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However, because no plasmid AmpC was detected in these farm isolates, resistance is likely to be 436 
due to mutations in the E. coli chromosomal ampC attenuator or promoter regions. In a study which 437 
used different phenotypic confirmation kits to differentiate between ESBL and AmpC, it was found 438 
that, out of 66 isolates, 58 isolates showed activity against cefepime and cefepime plus clavulanate, 439 
and 38 isolates showed CAZ activity; none of the AmpC strains showed activity against cefepime 440 
(Hansen et al. 2012). Besides, class D (OXA-type) ESBLs are poorly inhibited by clavulanic acid and 441 
therefore cannot be detected by the methods described here (Drieux et al. 2008; Naas et al. 2008). 442 
Complicated ESBL gene carriage patterns have been found elsewhere. In a study performed on a 443 
farm suffering from calf scour it was found that amongst E. coli isolates that were resistant to 444 
cefotaxime, in addition to the isolates that were positive for CTX and TEM, 5/48 calf and 28/60 cow 445 
isolates were blaCTX- and blaTEM-negative, and sequence analysis confirmed that these had mutations 446 
in the promoter region of the chromosomal ampC gene (Liebana et al. 2006). 447 
Dissemination of CTX-M genes via the food chain may also happen. In another study, on E. coli 448 
harbouring CTX-M genes and quinolone resistance genes, detected in healthy animals from a Czech 449 
zoological garden, the authors imply that the reason that zoo animals are carrying these genes may 450 
be due to spreading of MDR E. coli via the food chain according to their molecular analysis of the 451 
isolates (Dobiasova et al. 2013). In a study carried out on E. coli from farms in the UK, it was found 452 
that E. coli transconjugants harbouring blaCTX-M genes from cattle, chicken and turkey isolates were 453 
carrying 10, 8 and 7 other antimicrobial resistance genes respectively, and these mainly encoded 454 
resistances to older antibiotics. This study suggested that chicken and cattle CTX-M E. coli represent 455 
different populations (Toszeghy et al. 2012), and in a separate study, where there was the use of 3rd 456 
or 4th generation cephalosporin (ceftiofur and cefquinome) in livestock for 12 months prior to the 457 
analysis, E. coli isolates were nearly four times more likely to be ESBL positive (Snow et al. 2012). 458 
Samples from different sources have also been used to detect only ESBL genes, in this case the 459 
samples were faecal samples from pigs, cattle, chicken and sheep which were investigated at 460 
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slaughter. Only 13.7% of the bovine faeces samples showed positive ESBL producers (Geser et al. 461 
2012). Each farm has different policies, which can affect the prevalence of antimicrobial resistance. 462 
Watson and co-workers found that the increased prevalence of the CTX-M-15 E. coli in certain cattle 463 
groups and farm environments including calving pens was related to the husbandry, antimicrobial 464 
usage and hygiene (Watson et al. 2012). 465 
ERIC PCR has been used as a reliable method to differentiate between different genotypes of E. coli 466 
(Duan et al. 2009). There was no absolute distinction between isolate sources using ERIC PCR, as 467 
different isolates from different sources are found in most of the ERIC groups, except for group II 468 
and V and subgroup A of group IV that do not include any isolates from the slurry tank (Figure 5). 469 
This result is not surprising as all tested materials ultimately originated from the same source i.e. the 470 
cows. However, there was a significant difference (P≤ 0.001 using the AMOVA test) between the 471 
isolates from different sampling times, i.e. between group VI (2012) and the others (2014). Previous 472 
studies of E. coli from cattle faeces and farm environments showed strains were clonally related and 473 
carried the same CTX-M genes which were also seen in cultivated soil that was amended with 474 
manure one year before (Hartmann et al. 2012). In the current study genotyping showed that there 475 
was genomic diversity in the multi-resistant E.coli isolates with no evidence of clonal lines.  In 476 
addition identical genotypes had different antibiotic resistance profiles.  Both these findings suggest 477 
the presence of mobile resistance determinants in the population. 478 
In conclusion the data from our study reflect a complex picture of resistance gene carriage within 479 
the farm E. coli population with evidence of multiple antibiotic resistance gene carriage and ESBL 480 
activity caused by different beta-lactamases, of which there are examples of co-carriage in individual 481 
strains. There are common antibiotic resistance patterns with resistance to AMP, S10, OT, S300 and 482 
AMC, and a subgroup of ESBL producing strains are also present. The strains we have isolated 483 
represent a snapshot of the reservoir of resistance genes within the dairy herd and the farm 484 
environment, carried in one species of Enterobacteriaceae (E. coli) on one farm. The resistance 485 
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profile of the isolates may reflect a historical accumulation of resistance genes, and represents the 486 
antibiotic “resistome” present as an environmental reservoir of bacteria, mobile elements and 487 
genes. This may aid the understanding of the environmental drivers which lead to the retention of a 488 
reservoir of resistance genes in the commensal bacterial population and hence control their spread. 489 
Further studies on the molecular basis of resistance amongst those isolates and the mobility of them 490 
are now needed.   491 
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Multidrug and extended spectrum beta-lactamase resistant Escherichia coli 
isolated from a dairy farm. 
 
Figure 1. Percentages of MDR E.coli resistant to different numbers of antibiotics. 
 
Figure 2.  Percentage sensitivity to 17 antibiotics for 126 E. coli farm isolates. 
Blue bar indicates sensitive, red bar indicates intermediate sensitivity, green bar indicates lack of 
sensitivity, using CLSI (2013a,b) definitions. The Y axis represents the percentage of isolates. 
 
Figure 3.  Heatmap representation of zone of growth inhibition surrounding antibiotic assay discs 
to 17 antibiotics for 126 E. coli isolates.  
The size of the zone of clearing around the antibiotic discs is represented by the colour spectrum in 
the diagram, with red representing no zone of clearing (not sensitive), red through to orange 
(resistant- zone of clearing 10-22mm d pending on antibiotic), orange to yellow (sensitive-zone of 
clearing 17-27mm depending on antibiotic) and yellow to white representing a zone of clearing of 
30-37mm). A zone of >37mm indicates highly sensitive -white.  Presence of blaCTX-M or blaTEM or 
blaOXA is indicated by solid black lines, dotted blue lines, or solid red lines respectively. Notation of 
the antibiotics is as described in Table 1. The strain designation is described in the text.  TBX, TBX + 
CTX (cefotaxime) and CHROMagar ESBL represent the media used to isolate the strains. Strain 
numbers in blue typeface indicate strains which were not isolated on the same medium as other 
strains in the cluster.  
 
Figure 4. Percentages for ESBL and AmpC phenotypes amongst E. coli isolates resistant to 
cefotaxime. 
 
Figure 5. Dendogram of ERIC PCR profiles using Dice similarity coefficient and UPGMA cluster 
analysis for E. coli isolates. 
Clustering of ERIC-PCR profiles for E. coli isolates from the same farm using the Dice coefficient and 
UPGMA as described in Methods.  Clusters I-VI were formed at 50% similarity as designated using 
AMOVA analysis. Subclusters A, B and C of cluster IV were designated at 60%. Strain designation is 
described in the text. Antibiotic notation is as in Table 1.The horizontal blue line divides each main 
group I-VI which clustered at 50% similarity threshold, which is indicated by the vertical blue line. 
The red line subdivides group IV into its subclusters.  
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Table 1:  Antibiotic assay discs, abbreviations, and amount of antibiotic contained in each disc. 
 
ANTIBIOTIC Discs Content 
Beta-lactams  
Ampicillin (AMP) 10µg 
Amoxicillin-clavulanic acid (AMC)  20/10 μg 
Cefotaxime (CTX) 30 μg 
Ceftazidime (CAZ)  30 μg  
Aztreonam ( ATM) 30 μg 
Imipenem  (IMP) 10 μg 
Cefquinome (CFQ) 30 μg 
Ceftiofur (EFT) 30 μg 
Aminoglycoside  
Streptomycin (S10)  10µg 
Quinolones  
Ciprofloxacin  (CIP) 5 μg 
Enrofloxacin (ENR) 5 μg 
Nalidixic acid  (NA) 30 μg 
Sulphonamide/complex  
Trimethoprim-sulfamethoxazole 
(SXT) 
  1.25/ 23.75 μg 
Sulfonamide  (S300) 300 μg 
Phenicol  
Chloramphenicol  ( C ) 30 μg 
Tetracycline  
Oxytetracycline (OT) 30 μg 
Nitrofuran derivative  
Nitrofurantoin  (F) 300 μg 
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Oligonucleotide 
name 
Sequence Product 
size (bp) 
Reference 
CTX-M-F ATGTGCAGYACCAGTAARGTKATGGC 529
a 
(Dierikx et al. 
2012) CTX-M-R TGGGTRAARTARGTSACCAGAAYSAGC GG 
TEM-F GCGGAACCCCTATTT G 964 
TEM-R ACCAATGCTTAATCAGTGAG 
SHV-F- TTATCTCCCTGTTAGCCACC 796 
SHV-R- GATTTGCTGATTTCGCTCGG 
OXA-1-F- ATGAAAAACACAATACATATCAACTTC GC 820 
OXA-1-R- GTGTGTTTAGAATGGTGATCGCAT T 
OXA-2-F- ACGATAGTTGTGGCAGACGAAC 601 
OXA-2-R- ATYCTGTTTGGCGTATCRATATTC 
MultiACC-F- CACCTCCAGCGACTTGTTAC 346 (Dallenne et al. 
2010) MultiACC-R-  GTTAGCCAGCATCACGATCC 
MultiMOX-F- GCAACAACGACAATCCATCCT 895 
MultiMOX-R- GGGATAGGCGTAACTCTCCCAA 
MultiDHA-F- TGATGGCACAGCAGGATATTC 997 
MultiDHA-R- GCTTTGACTCTTTCGGTATTCG 
MultiCIT-F- CGAAGAGGCAATGACCAGAC 538 
MultiCIT-R- ACGGACAGGGTTAGGATAGYb 
MultiEBC-F- CGGTAAAGCCGATGTTGCG 683 
MultiEBC-R- AGCCTAACCCCTGATACA 
MultiFOX-F- CTACAGTGCGGGTGGTTT 162 
MultiFOX-R- CTATTTGCGGCCAGGTGA 
AmpC-F- GATCGTTCTGCCGCTGTG 271  
(Peter-Getzlaff 
et al. 2011) 
AmpC-R- GGGCAGCAAATGTGGAGCAA 
ERIC-F- ATGTAAGCTCCTGGGGATTCAC variable (Versalovic et 
al. 1991) ERIC-R- AAGTAAGTGACTGGGGTGAGCG 
a
(R is a purine; Y is a pyrimidine; S is G or C) 
List of primers used in this study for detection of ESBL genes (CTX-M TEM, SHV, and OXA), plasmid-
mediated ampC (ACC, MOX, DHA, CIT, EBC and FOX). The correct PCR product sizes are shown for 
each primer pair. The ERIC PCR primer sequences are also shown; PCR products from amplifications 
using ERIC are variable in size. 
 
 
 
 
 
 
 
 
 
Table 2: PCR primers used for detection of beta-lactamase genes. 
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Inhibition zone sizes for ESBL E. coli isolates using the ESBL (left columns: CTX to Cefepime +C) and AmpC confirm (right 
columns CTX to FOX) test kits. D is the difference between the 2 previous values (or the difference between antibiotic 
alone and antibiotic with supplement), 5 mm or greater difference for D indicates positive results for the test, which has 
been highlighted in red. Strain numbers in red typeface indicate strains with both ESBL and AmpC activity. 
ANTIBIOTICS 
 sample ID            CTX 
     
CTX+C               D          CAZ      CAZ+C              D            FE       FE +C               D     CTX CTCCX               D           CAZ    CAZCX               D            FOX 
BC13 
 
20 23 3 20 25 5 30 30 0 20 26 6 20 25 5 15 
BCC1 0 30 30 16 26 10 16 30 14 0 3 3 16 17 1 25 
BCC11 21 21 0 19 20 1 26 30 4 22 26 4 19 26 7 18 
BCC12 22 24 2 19 24 5 25 28 3 22 30 8 20 30 10 20 
BCC14 24 25 1 21 24 3 30 31 1 25 31 6 22 29 7 18 
BCC15 20 20 0 18 20 2 23 25 2 20 28 8 15 29 14 20 
BCC16 20 22 2 18 22 4 25 25 0 20 30 10 18 30 12 20 
BCC2 15 28 13 25 26 1 20 30 10 15 18 3 25 28 3 28 
BCC3 24 26 2 21 24 3 30 31 1 24 29 5 20 25 5 16 
BCC4 23 25 2 20 22 2 29 29 0 23 30 7 20 29 9 16 
BCC5 23 24 1 21 23 2 29 29 0 22 27 5 20 26 6 16 
BCC6 22 25 3 20 25 5 30 31 1 22 24 2 20 20 0 22 
BCC7 23 24 1 20 25 5 30 30 0 23 30 7 20 30 10 18 
BCC8 23 24 1 21 22 1 28 28 0 25 30 5 23 29 6 16 
BCC9 22 24 2 19 24 5 27 28 1 23 25 2 21 25 4 18 
BCE1C 0 30 30 15 30 15 18 30 12 0 3 3 15 17 2 25 
BCE2 0 25 25 15 25 10 17 30 13 0 3 3 16 17 1 25 
BCE3 14 25 11 23 25 2 16 28 12 14 18 4 23 27 4 25 
BCE4 10 29 19 15 25 10 17 30 13 10 12 2 15 16 1 26 
BCE5 11 29 18 16 25 9 15 29 14 11 15 4 16 19 3 35 
BLC1 21 24 3 20 21 1 26 27 1 21 31 10 20 30 10 20 
BLC2 21 23 2 18 22 4 27 29 2 21 27 6 18 25 7 17 
BLC3 20 24 4 18 21 3 25 25 0 21 26 5 19 25 6 15 
BLC4 28 29 1 21 28 7 25 25 0 28 28 0 21 25 4 20 
BLC5 19 25 6 20 25 5 30 30 0 20 28 8 20 26 6 17 
BLC6 20 20 0 18 20 2 25 25 0 20 24 4 19 27 8 20 
BLC8 20 24 4 19 21 2 25 25 0 20 24 4 21 27 6 19 
BLC9 21 21 0 18 21 3 25 27 2 21 30 9 20 30 10 20 
BS9 10 30 20 17 28 11 19 32 13 10 14 4 17 18 1 22 
BSC1 23 27 4 20 23 3 30 34 4 23 30 7 20 30 10 15 
BSC10 24 26 2 21 25 4 31 31 0 26 33 7 23 31 8 16 
BSC13 22 24 2 20 22 2 28 28 0 22 26 4 20 26 6 17 
BSC14 23 26 3 20 25 5 28 28 0 23 31 8 20 30 10 16 
BSC15 22 24 2 20 20 0 28 30 2 20 25 5 18 24 6 20 
BSC16 23 25 2 20 22 2 30 30 0 24 32 8 22 30 8 16 
BSC17 23 24 1 20 24 4 28 28 0 23 30 7 21 28 7 14 
BSC18 22 24 2 20 23 3 30 30 0 22 30 8 20 29 9 17 
BSC19 20 25 5 20 24 4 26 28 2 20 30 10 20 30 10 18 
BSC2 22 24 2 20 23 3 28 30 2 21 30 9 20 27 7 15 
BSC20 24 27 3 20 25 5 30 30 0 25 30 5 20 29 9 14 
BSC21 19 21 2 17 21 4 25 25 0 19 30 11 19 29 10 15 
BSC22 10 30 20 15 21 6 22 30 8 10 12 2 15 17 2 25 
BSC3 22 24 2 20 25 5 30 30 0 23 29 6 20 28 8 15 
BSC4 22 25 3 20 25 5 28 31 3 24 32 8 20 31 11 15 
BSC5 23 24 1 20 24 4 30 31 1 23 31 8 20 30 10 16 
BSC6 22 25 3 20 24 4 30 30 0 22 27 5 20 24 4 18 
BSC7 23 25 2 22 26 4 29 30 1 23 30 7 22 29 7 15 
BSC9 21 25 4 20 24 4 24 28 4 21 30 9 21 29 8 16 
BSE2 14 30 16 17 28 11 20 30 10 14 15 1 17 19 2 25 
BSE3 10 27 17 14 25 11 19 27 8 10 14 4 14 18 4 27 
BSE6 17 30 13 17 27 10 16 27 11 15 15 0 17 18 1 25 
BSE8 20 30 10 26 28 2 30 32 2 20 24 4 26 30 4 24 
BSE9 28 32 4 30 31 1 34 36 2 28 32 4 30 31 1 18 
NCTC13353 0 28 28 13 30 17 14 30 16 0 0 0 13 13 0 25 
E.cloacae 9 11 2 9 11 2 25 25 0 9 24 15 9 24 15 6 
Table 3: Phenotypic ESBL resistance in E. coli isolates 
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Figure 1: Percentage of MDR E.coli resistant to different numbers of antibiotics 
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Figure 2. Percentage  sensitivity or resistance to 17 antibiotics for 126 E. coli farm isolates. (1) 
Beta-lactams; (2) Aminoglycoside; (3)  Quinolones; (4) Sulphonamide/complex; (5) Phenicol; 
(6) Tetracycline, and (7) Nitrofuran derivative 
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Figure 4. Percentage of ESBL and AmpC phenotypes amongst E. coli isolates resistant to cefotaxime and/ 
or ceftazidime.  
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